| Drug Name |
Insulin (human) |
| Drug ID |
BADD_D01159 |
| Description |
Human Insulin, also known as Regular Insulin, is a short-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Human insulin is produced by recombinant DNA technology and is identical to endogenously produced insulin. Typically prescribed for the management of diabetes mellitus, insulin is a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is released from the pancreas following a meal to promote the uptake of glucose from the blood into internal organs and tissues such as the liver, fat cells, and skeletal muscle. Absorption of glucose into cells allows for its transformation into glycogen or fat for storage. Insulin also inhibits hepatic glucose production, enhances protein synthesis, and inhibits lipolysis and proteolysis among many other functions. |
| Indications and Usage |
Human insulin is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. |
| Marketing Status |
approved; investigational |
| ATC Code |
A10AB01; A10AC01; A10AD01; A10AE01; A10AF01 |
| DrugBank ID |
DB00030
|
| KEGG ID |
D00085
|
| MeSH ID |
D007328
|
| PubChem ID |
118984375
|
| TTD Drug ID |
D0R6CD
|
| NDC Product Code |
0002-8803; 47918-874; 62381-0509; 47918-880; 0338-0126; 0002-8501; 0002-8315; 0002-8715; 0002-8215; 0002-0013; 0002-2510; 47918-878; 47918-891; 0002-8805; 62381-0719; 0002-8824; 0002-0113; 0002-0485; 0002-9307; 62381-0319; 47918-898; 0002-2045; 0002-0096; 0002-0095; 0002-0119; 47918-902 |
| UNII |
Not Available
|
| Synonyms |
Insulin | Insulin, Regular | Regular Insulin | Soluble Insulin | Insulin, Soluble | Insulin A Chain | Sodium Insulin | Insulin, Sodium | Novolin | Iletin | Insulin B Chain | Chain, Insulin B |
